Comerica Bank
CORT icon

Comerica Bank’s Corcept Therapeutics CORT Stock Holding History

Comerica Bank’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.21M Sell
34,737
-2,141
-6% -$168K ﹤0.01% 1403
2025
Q3 		$3.06M Sell
36,878
-3,440
-9% -$249K 0.01% 936
2025
Q2 		$2.96M Buy
40,318
+2,494
+7% +$181K 0.01% 936
2025
Q1 		$4.32M Sell
37,824
-817
-2% -$49.7K 0.02% 741
2024
Q4 		$1.95M Buy
38,641
+600
+2% +$31.4K 0.01% 1156
2024
Q3 		$1.76M Buy
38,041
+7,200
+23% +$256K 0.01% 1215
2024
Q2 		$1M Sell
30,841
-1,754
-5% -$48K ﹤0.01% 1492
2024
Q1 		$821K Sell
32,595
-4,659
-13% -$110K ﹤0.01% 1643
2023
Q4 		$1.21M Buy
37,254
+203
+0.5% +$5.57K 0.01% 1440
2023
Q3 		$1.01M Buy
+37,051
New +$1.07M 0.01% 1451
2022
Q4 		$1.21M Sell
52,695
-16,145
-23% -$405K 0.01% 1353
2022
Q3 		$2M Sell
68,840
-8,570
-11% -$229K 0.02% 1041
2022
Q2 		$2.15M Sell
77,410
-370
-0.5% -$8.06K 0.02% 1056
2022
Q1 		$1.79M Sell
77,780
-1,975
-2% -$42K 0.01% 1224
2021
Q4 		$1.39M Sell
79,755
-10,142
-11% -$206K 0.01% 1384
2021
Q3 		$1.68M Sell
89,897
-3,477
-4% -$72.8K 0.01% 1405
2021
Q2 		$1.9M Sell
93,374
-8,087
-8% -$180K 0.01% 1336
2021
Q1 		$2.44M Sell
101,461
-3,602
-3% -$96.2K 0.01% 1240
2020
Q4 		$2.95M Buy
105,063
+257
+0.2% +$5.42K 0.02% 1049
2020
Q3 		$1.87M Sell
104,806
-303
-0.3% -$4.83K 0.01% 1170
2020
Q2 		$1.72M Buy
105,109
+5,237
+5% +$73.6K 0.01% 1179
2020
Q1 		$1.31M Buy
99,872
+3,432
+4% +$42.5K 0.01% 1175
2019
Q4 		$1.26M Buy
96,440
+772
+0.8% +$10.7K 0.01% 1408
2019
Q3 		$1.35M Sell
95,668
-2,501
-3% -$30.7K 0.01% 1344
2019
Q2 		$1.05M Sell
98,169
-5,151
-5% -$57.4K 0.01% 1507
2019
Q1 		$1.26M Buy
103,320
+1,561
+2% +$19.4K 0.01% 1435
2018
Q4 		$1.19M Sell
101,759
-460
-0.5% -$6.08K 0.01% 1441
2018
Q3 		$1.25M Sell
102,219
-41,264
-29% -$577K 0.01% 1459
2018
Q2 		$1.99M Buy
143,483
+43,464
+43% +$756K 0.01% 1267
2018
Q1 		$1.82M Buy
100,019
+2,812
+3% +$52.1K 0.01% 1285
2017
Q4 		$2.44M Buy
+97,207
New +$1.76M 0.02% 1142

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Comerica Bank's CORT Position: Q4 2025 in Review

Comerica Bank reduced its Corcept Therapeutics (CORT) stake by 5.8% in Q4 2025, selling an estimated $168K and leaving 34,737 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1403.

Comerica Bank first reported a position in CORT in Q4 2017 and has held it in 31 quarters since. The position peaked at $4.32M in Q1 2025. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.

  • Comerica Bank held 34,737 shares of Corcept Therapeutics worth $1.21M as of Q4 2025.
  • Comerica Bank sold 2,141 Corcept Therapeutics shares in Q4 2025, an estimated $168K.
  • Corcept Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #1403 holding.
  • Comerica Bank first reported a position in Corcept Therapeutics in Q4 2017 and has held it in 31 quarters since.
  • Comerica Bank's Corcept Therapeutics position peaked at $4.32M in Q1 2025.
  • 389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.